Mounjaro®
Starting from £179.99/mo
Start journey Learn moreThe Wegovy multi-dose pen delivers four weekly doses from a single device, and using it correctly matters as much as the dose itself. Each pen contains semaglutide, a GLP-1 receptor agonist licensed in the UK for weight management, and it is available only on prescription following a clinical assessment. Getting the technique right from the first injection sets the foundation for everything that follows — so this guide walks through the real decisions you face each week, based on the guidance published on the NHS semaglutide medicines page and the manufacturer's instructions.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Consistency matters more than perfection. Pick a day that fits your routine (a Monday morning, a Sunday evening) and stick to it. If you miss your usual time, the injection can be given up to five days late; after that, skip it and resume on your next scheduled day. Your prescriber and the Patient Information Leaflet carry the definitive guidance on missed doses, so treat anything here as orientation rather than instruction.
Where you inject shapes how well semaglutide is absorbed. The three licensed sites are the abdomen (avoiding the two inches around the navel), the front of the thigh, and the outer upper arm. Rotating within and between those zones prevents the small lumps or skin changes that repeated injections in one spot can cause. A useful habit: keep a simple mental note of last week's site and move to the next area in sequence.
One misconception worth setting aside gently: many people assume injecting into the upper arm is somehow less effective or more painful than the abdomen. The evidence does not support that. All three sites are clinically equivalent for absorption; comfort and convenience are the deciding factors. If you find one site easier, use it, just keep rotating within it.
For a fuller picture of how the multi-dose format works alongside the wider Wegovy pen range, the Wegovy multi-dose pen overview covers the device in more detail.
Before each injection, take the pen from the fridge and let it reach room temperature for about 15–30 minutes. Injecting cold semaglutide is not dangerous, but it is noticeably more uncomfortable and there is no reason to do it unnecessarily.
Check the liquid in the pen window. Semaglutide solution should be clear and colourless to slightly yellow, with no particles floating in it. If it looks cloudy, discoloured or contains visible matter, do not use it, contact your pharmacy or prescriber. This check takes five seconds and is worth every one of them.
Attach a new needle for this injection only. Push the outer cap onto the needle port firmly, then remove the outer and inner needle caps. Never pre-attach a needle and store the pen that way; leaving a needle on between doses risks air entering the cartridge and the solution leaking or drying at the tip. Once the needle is on, you are ready to inject.
Clean the injection site with an alcohol swab and let it dry fully before inserting the needle, injecting through wet skin stings more and slightly increases infection risk. Pinch a fold of skin, insert the needle at a 90-degree angle, press the dose button until the counter clicks forward by one, then hold for six seconds before withdrawing. That six-second pause is the step most people skip on the first attempt; it ensures the full dose is delivered. If you are working through the introductory strengths, our guide on how to use the Wegovy 0.5 mg pen walks through the process in detail, and there is a dedicated page covering how to use the Wegovy 1 mg pen when you reach that stage of your dose escalation.
If you are thinking about what this treatment costs as a private patient, our Wegovy cost guide explains what the UK market currently looks like and what a legitimate price should include.
The multi-dose pen lives in the fridge between weekly injections. Keep it away from the freezer compartment and from direct contact with the cooling element at the back of the fridge shelf, freezing destroys the medicine. If the pen has accidentally frozen, do not use it.
Storage outside the fridge is sometimes necessary: travelling, staying somewhere without reliable refrigeration, or a power cut. The Patient Information Leaflet specifies the exact number of hours the pen can safely be kept at room temperature; because that window can differ between product batches and is subject to update, we do not quote a figure here. The leaflet is the authority. For specific guidance on travelling with Wegovy, speaking to your prescriber or pharmacist is the right move.
Needle disposal is non-negotiable. Used needles are clinical waste. Recap the outer cap, remove the needle from the pen and drop it into a sharps container immediately. Placing used needles in household bins creates a real risk of needlestick injury for refuse workers. Most GP surgeries and pharmacies accept full sharps containers for safe disposal.
When all four doses have been used, the dose counter on the pen reaches zero and the button locks, and our page on how to use the Wegovy 4-dose pen covers exactly what to expect as you work through each dose. Dispose of it through your pharmacy or sharps scheme, not in the household bin. For context on the different Wegovy formats available, the Wegovy doses guide covers how the 0.25mg through 2.4mg schedule is structured across the pen range.
Semaglutide's side-effect profile is well characterised. Nausea, loose stools, constipation and indigestion are the most commonly reported effects, particularly in the weeks after a dose increase. They are not trivial if you are experiencing them, but they do typically ease as your body adjusts. Staying well hydrated, eating smaller portions and avoiding very fatty or rich meals reduces the severity for most people.
Some symptoms need prompt medical attention rather than waiting to see if they pass. Severe stomach pain that radiates through to the back (with or without vomiting) can indicate pancreatitis, which the MHRA specifically flagged in a Drug Safety Update for GLP-1 medicines in January 2026 as a known, infrequent but serious risk. Seek medical help immediately for pain of that character. The same applies to signs of a serious allergic reaction: swelling of the face, throat or tongue, difficulty breathing, or a severe rash.
If you are managing any change in how you feel day to day, or if a dose increase has raised questions, reaching out to your prescriber is always the right call. At nume, aftercare is available seven days a week. You can read more about how our team works on the about us page, or explore the broader picture of weight-loss treatment options at our weight-loss overview.
Wegovy is a prescription-only medicine. A prescriber decides whether it is appropriate for you, at what dose, and for how long. If you have not yet started and want to understand whether you might be eligible, check your eligibility with a free consultation, reviewed the same day by a GPhC-registered prescriber.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.